Phibro Animal Health Corporation - (PAHC): Price and Financial Metrics
Phibro Animal Health Corporation - (PAHC)
Today's Latest Price: $20.97 USD
Updated Jan 27 6:55pm
Add PAHC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 78 in Medical - Services
See all "A" rated Strong Buy stocks
PAHC Stock Summary
- Phibro Animal Health Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 89.41% of US listed stocks.
- Phibro Animal Health Corp's stock had its IPO on April 11, 2014, making it an older stock than just 24.78% of US equities in our set.
- Of note is the ratio of Phibro Animal Health Corp's sales and general administrative expense to its total operating expenses; 88.02% of US stocks have a lower such ratio.
- Stocks with similar financial metrics, market capitalization, and price volatility to Phibro Animal Health Corp are PRIM, ARC, CRI, KRO, and SGMA.
- PAHC's SEC filings can be seen here. And to visit Phibro Animal Health Corp's official web site, go to www.pahc.com.
PAHC Stock Price Chart Interactive Chart >
PAHC Price/Volume Stats
| Current price | $20.97 | 52-week high | $29.38 |
| Prev. close | $21.31 | 52-week low | $16.27 |
| Day low | $20.60 | Volume | 131,700 |
| Day high | $21.72 | Avg. volume | 121,994 |
| 50-day MA | $19.59 | Dividend yield | 2.29% |
| 200-day MA | $21.35 | Market Cap | 848.30M |
Phibro Animal Health Corporation - (PAHC) Company Bio
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company was founded in 2000 and is based in Teaneck, New Jersey.
PAHC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $20.97 | $17.5 | -17% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Phibro Animal Health Corp. To summarize, we found that Phibro Animal Health Corp ranked in the 47th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for PAHC, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 68. Notably, its equity weight is greater than merely 19.73% of US equities in the Healthcare sector yielding a positive free cash flow.
- Phibro Animal Health Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 7.47% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -18% |
| 1% | -17% |
| 2% | -17% |
| 3% | -16% |
| 4% | -15% |
| 5% | -14% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as PAHC, try FGEN, BDX, ADUS, AMED, and IQV.
Loading social stream, please wait...